会议报道

中国(合肥)生物技术与产业发展论坛成功举行我国政府高度重视生物技术与生物产业的发展,在《国民经济和社会发展第十一个五年规划纲要》、《国家中长期科学技术发展规划纲要》中,都将生物技术列为实现重点跨越的领域。今年4月,国务院办公厅转发了《生物产业发展“十一五”规划》,明确提出了“十一五”期间,我国生物产业的发展思路、总体目标、主要任务和发展重点。在这样的大背景下,中国生物工程学会与安徽省科学技术协会、合肥市人民政府联合举办“中国(合肥)生物技术与产业发展论坛”,在促进和推动我国生物技术的研究与生物产业的发展方面…     

日本制定生物技术发展战略

在“生物技术立国”的口号下,日本政府正在加紧制定生物技术和生物产业的基本战略,五年内投资２万亿日元。生物技术是日本在２１世纪创立新产业的主要技术领域之一。科技、通产、农林、厚生、文部等五省、厅在年初联合制定了《创造生物技术产业的基本方针》。６月上旬,农业、化学、电子、机械、食品、造纸、纺织、能源、医药等数十家大企业和有关团体召开了“日本生物产业人会议”,并发表紧急建议,要求政府早日制定发展生物技术和产业的国家战略。目前上述五省、厅正在加紧制定发展生物技术和生物产业的基本战略。该基本战略把研究开发…     

中国生物产业发展报告2014

<正>化学工业出版社出版本书由国家发展和改革委员会高技术产业司与中国生物工程学会组织编写,是《中国生物产业发展报告》系列图书的第13本。全书包括7篇,共42章,对生物产业发展战略与政策、生物产业发展现状与趋势、生物技术发展前沿与热点、生物产业投融资情况、生物技术专利、国家生物产业基地情况、重点行业协(学)会发展报告等进行了阐述和说明,从多角度对中     

科技图书

2013中国生物技术发展报告 中华人民共和国科学技术部社会发展科技司,中国生物技术发展中心编著 科学出版社2013年10月出版 本书以2013年我国生命科学和生物技术领域的主要成就为主线,重点介绍了组学技术、干细胞技术和再生医学技术等前沿生物技术发展的国内外情况,以及我国生物医药、生物农业、生物制造、生物环保、生物能源的发展情况,阐述了2013年我国出台支持生物产业发展的相关政策。     

印度：力图成为亚洲生物产业的隐形冠军

生物技术产业始终是印度政府扶持的重点。1986年印度就设立了生物技术部（DBT）,协调和管理生物技术产业。2007年11月印度启动实施《国家生物技术发展战略》,对生物技术的政府投入达到每年3.2亿多美元,增长了3.5倍。同时,印度力图通过完善创新体系、实施产业促进计划、加强人才队伍建设、出台优惠政策、强化产学研协同创新、吸引跨国企业进驻等措施,加速生物科技和产业发展。2005年印度有生物技术公司800多家,2006年生物产业收入的58%来自出口。外包服务、生物信息技术产业等是其优势领域。     

《生物产业技术》创刊五周年回顾之产业动态篇

2005年《生物产业技术》创办之时,也正是我国生物产业技术面临机遇与发展的重要时期．党中央、国务院将生物产业作为我国战略性高技术产业迎头赶上的领域进行重点部署并给予高度重视。生物产业成为了我国调整经济结构．实现传统经济增长方式转换的朝阳产业。作为生物技术领域唯一一本面向产业的刊物,自创办之初就将自身定位于侧重生物技术实验研究、关注生物技术产业发展,明确了办刊方针即为：     

《生物产业技术》创刊五周年回顾之医药生物技术篇

医药生物技术产业是生物技术产业最重要的组成部分,是《生物产业技术》杂志重点关注领域之一。《生物产业技术》自2005年创刊以来,一直追踪医药生物行业的热点、关注医药生物行业的发展,期待将医药生物产业的精彩展示给产业界和大众。杂志通过“公司新闻”、“前沿技术”、“新药连载”、”专题”等多种形式记录了医药生物产业研发以及医药生物制造企业、研发机构、合同研发外包企业、投资机构等发展实践历程。     

现代生物技术产业研究(Ⅱ)－武汉生物技术产业发展的重点、目标及政策机制

武汉生物技术产业发展的宗旨是:集中武汉的生命科学与技术领域的力量,突出重点,发挥优势,从科研、开发和产业三个方面入手,用5～10年的时间,建立起生命科学研究、开发及其产业的发展体系,在若干领域达到国际或国内的领先水平,把武汉地区生命科学领域的科研优势转化为产业优势,形成强大的生物技术产业链;应用生命科学的理论和现代生物技术新成果的产业化大力发展具有生态、环保、经济、社会效益的生物技术产业及其相关产业 ,通过新技术、新产品的研究开发及其产业化改造传统产业,调整产业结构和产品结构,形成武汉新的经济增长点和支撑点.搭上国际生物高技术产业头班车,迎接生物经济时代到来 . 武汉现代生物技术产业的重点发展领域和重点发展项目分别如下:     

中国工业生物技术发展态势分析与展望

现代生物技术逐渐进入大规模产业化阶段,全球生物经济快速发展,工业生物技术作为生物经济的支柱,支撑生物制造、生物能源、生物农业、生物医药、生物环保和生物服务等产业发展。分析和展现了中国近期在工业生物技术领域基础研究、应用研究、技术转化与产业发展方面取得的进展和成就,反映了中国工业生物技术发展的现状与趋势,并提出了未来发展的挑战与机遇。     

我国的生物产业状况与前景

经过近20年的发展,我国生物产业取得了快速发展,为经济建设和社会发展做出了重要贡献,总体水平在发展中国家中处于领先地位。综述了我国生物产业的发展现状,重点介绍了生物制药、组织工程材料、农业生物技术等领域的状况和成就,简要分析了我国与国外在生物产业上的优势和差距,并展望了生物产业广阔的发展前景。     

生物技术创新驱动天津经济社会高质量发展

生物技术作为21世纪最重要的创新技术之一,颠覆性、引领性、系统性特征日益凸显,智能化、汇聚化、变革化模式不断涌现,在引领未来经济社会发展中的战略地位日益突出。本文深入剖析了天津市发展生物技术和生物产业的基础和优势,介绍了天津市近年来在支持生物技术和生物产业方面的总体部署和举措,以及在支撑生物产业发展方面取得的重要进展,指出大力发展生物技术是天津市实现高质量发展的重要路径,并对生物技术支撑国家和区域经济社会可持续发展、助力天津全面建成社会主义现代化大都市进行了展望。     

泰国生物产业发展现状和趋势分析

泰国是农产品生产和出口大国,政府十分重视生物产业的发展,通过建立高层管理机构、出台优惠政策、制定发展规划,在生物农业、生物医药和生物能源等产业方面取得了较好的进展。未来泰国将更加重视政府指导作用,进一步完善法规建设,加大人才引进力度,实施产业优惠政策,加强生物资源和知识产权保护,重点发展生物农业、生物医药和生物能源产业。     

我国各区域生物产业竞争力评价及实证分析

生物经济时代开启了人类新一波技术产业革命,我国针对生物产业作出的战略部署已经取得了明显成效,但在生物产业发展过程中仍存在区域发展不平衡等问题。为综合评价我国各区域生物产业竞争力现状,文中从生物医药、生物能源、生物农业和生物工业4个细分产业角度构建了生物产业整体竞争力评价指标体系,通过层次分析法确定了各评价指标的权重,并通过实证分析计算了我国不同地区生物产业的综合竞争力指数。评价结果表明,我国各区域生物产业竞争在空间上呈现梯度分布现象。针对此,文中从实施乡村振兴战略、推进区域协调发展战略、深化生物产业供给侧结构性改革和建立区域统一的信息协作网络体系4个角度提出了相关政策建议。     

韩国生物产业发展现状和趋势分析

自上世纪80年代以来,韩国生物产业迅猛发展。从政策、经费投入、机构及产业情况等对韩国生物产业情况进行综述,并展望了发展趋势,以期对我国生物产业发展起到借鉴作用。     

全球生物产业发展现状及政策启示

生物经济时代正在引发人类新一波技术和产业革命,并已成为了全球主要发达国家和新兴经济体抢占的制高点。文中从生物医药产业、转基因作物种植产业、生物能源产业以及生物基化学品产业4个角度分析了全球生物产业发展的时空特征,概括总结了全球生物产业发展的主要特点,并进一步针对我国生物产业发展中存在的瓶颈问题提出政策建议,对我国生物经济的未来发展具有指导意义。     

The cholera epidemics and the development of public health in Meiji Japan. 2. Strength and weakness of public health politics

We present here the beginnings of public health politics in Meiji Japan (1868-1912). Due to a two century isolation of Japan, public health concepts developed in the West from the end of the 18th century were foreign in premodern Japan. Due to its isolation, Japan was also relatively preserved from some acute infectious diseases such as cholera. In this paper, we investigate the role of cholera epidemics in the emergence of public health concepts in the peculiar context of Meiji Japan. We show that chronic diseases such as tuberculosis and leprosy were neglected for a long time and that the Meiji government set priority on acute infectious diseases that were considered as long as they disturbed public order. Nevertheless, some physicians and government officials considered issues of welfare and poverty. We also review some emerging concepts of social medicine. We try to show that in Japan as well as in western nations public health politics were not exempt of contradictions and paradoxes and a permanent tension existed between coercitive policies and conceptions of welfare and rights to health.     

Biotechnology and bioeconomy in China

From the review of the achievements and advantages in the development of biotechnology (BT) and bioindustry in China, it is clear that the bioeconomy would provide a tremendous opportunity for China to develop sustainably or even surpass a few developed countries. A long-term vision has been made to guide the research and development and industrialization of BT in China. This review detailed the strategies, targets, priorities, and key technologies in each stage. Furthermore, the reviewers expatiated on the establishment of the favorable policies, the foundation of the professional groups, the establishment of the advanced laboratories or centers, the investment mechanisms, the development and evaluation of biosafety, the encouragement and support for the international collaborations and exchanges, and the establishment of the general organizational structure.     

The cholera epidemics and the development of public health in Meiji Japan. 1. Modernity, cholera, and health thought

We present here the beginnings of public health politics in Meiji Japan (1868-1912). Due to a two century isolation of Japan, public health concepts developed in the West from the end of the 18th century were foreign in premodern Japan. Due to its isolation, Japan was also relatively preserved from some acute infectious diseases such as cholera. In this paper, we investigate the role of cholera epidemics in the emergence of public health concepts in the peculiar context of Meiji Japan. We show that chronic diseases such as tuberculosis and leprosy were neglected for a long time and that the Meiji government set priority on acute infectious diseases that were considered as long as they disturbed public order. Nevertheless, some physicians and government officials considered issues of welfare and poverty. We also review some emerging concepts of social medicine. We try to show, that in Japan as well as in Western nations, public health politics were not exempt of contradictions and paradoxes and a permanent tension existed between coercitive policies and conceptions of welfare and rights to health.     

Development of applications of industrial enzymes from Malaysian indigenous microbial sources

Malaysian enzyme industry is considered almost non-existence, although the import volume is large. Realizing the importance of enzymes, encompassing a wide range of applications in bioindustry, the development of home grown technologies for enzyme production and applications becomes one of the national priorities in industrial biotechnology. Enzyme production from indigenous microbial isolates was performed either by submerged or solid state fermentation processes. Based on its wide and unique spectrum of properties, enzymes have been developed for wide applications in various industrial processes. The development of the enzyme catalysed applications is based on the modification of the reaction systems to enhance their catalytic activities. Some of the applications of the industrial enzymes include the fine chemicals production, oleochemicals modification, detergent formulation, enzymatic drinking of waste papers, animal feed formulation and effluent treatment processes. Enzymes have also shown to be successfully used as analytical tool in the determination of compounds in body fluids. Although, most of these enzyme catalysed reactions were performed in aqueous phase, the use of enzymes in organic solvents was found to be significant for the production of new chemicals.     

Japan's innovation for global health – GHIT's catalytic role

The global fight against infectious diseases, both emerging and re-emerging, endures. Japan's commitments and reputation as a good global citizen and its responsibility to uphold domestic and international human security mean that it is in Japan's best interest to leverage its innovative and technological capabilities for global infectious disease prevention and control. The Global Health Innovative Technology Fund (GHIT Fund), an international non-profit organization based in Tokyo, Japan, was established by the Japanese government, multiple Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation as the first fund of its kind, with an aim to tackle the global burden of infectious diseases by facilitating and funding global health R&D of drugs, vaccines, and diagnostics. Since its inception in 2013, the GHIT Fund has invested more than 209 million USD in more than 90 projects, which consist of collaborations among Japanese and non-Japanese entities, six of which have already progressed to clinical stage development. Japan will continue to play a major role in the global health arena by further advancing R&D innovations for infectious diseases.